Arun Pandit (R) The official website of Arun Pandit
Interaction with Dr. Peter Siman CEO of IntraGel Therapeutics
And at times you meet founders and innovators who are building a solution that’s not just an optimized version of the current offering but something that totally changes the way things are done and has the power to revolutionize the industry and the human race.
It was a pleasure interacting with one such gentleman Dr. Peter Siman CEO of IntraGel Therapeutics.
The extreme side effects associated with chemotherapy treatments lead to patients quitting the courses of treatment, refusing to take any course, or them being essentially unfit for the treatment as their BMI and general health condition is very low.
These unfit patients are ~30% of the total oncology patients, which in the case of head and neck cancer (HNC) grow to 50% of the total HNC patients.
Consequently, those patients are hopeless and helpless in the battle against cancer.
Intragel technology is targeting those patients with intratumoral, safe, and sustained release of chemotherapy drugs, giving those unfit patients a second chance to fight cancer back.
We at Hyphen SCS are inspired by your work and are proud to be a part of the same cohort at MassChallenge Israel.
Looking forward to your tremendous growth story!
#drpetersiman#intragel#intrageltherapeutics#cancer#arunpandit#hyphenscs#oncology#founders#technology#growth#health#building#ceo#power#building#work#chemotherapy#healthcare#health#research#researchanddevelopment#patients
Interaction with Dr. Peter Siman CEO of IntraGel Therapeutics
